thiamine has been researched along with Cochlear Hearing Loss in 57 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive inherited disorder characterised by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 7.88 | Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child. ( Altaf, C; Fatima, S; Khadim, MT; Khurshid, A; Malik, HS; Sajjad, Z, 2018) |
| " Arrhythmia in thiamine responsive megaloblastic anemia syndrome." | 7.88 | Arrhythmia in thiamine responsive megaloblastic anemia syndrome. ( Akın, L; Argun, M; Baykan, A; Hatipoğlu, N; Kurtoğlu, S; Narin, N; Şahin, Y, 2018) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 7.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive disorder characterized by diabetes mellitus (DM), progressive sensorineural deafness, and thiamine-responsive anemia." | 7.72 | Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome. ( Calikoglu, AS; Lagarde, WH; Moats-Staats, BM; Underwood, LE, 2004) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 7.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "This case demonstrates Leber congenital amaurosis can present as the first clinical feature before systemic manifestations." | 5.72 | Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome. ( Sui, R; Sun, Z; Wu, S; Yao, F; Yuan, Z, 2022) |
| "Rogers syndrome is an autosomal recessive disorder resulting in megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 5.32 | Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family. ( Aronheim, A; Assaraf, YG; Baron, D; Drori, S, 2003) |
| "Wolfram syndrome, Kearns-Sayre syndrome, thiamine-responsive megaloblastic anemia, and maternally inherited diabetes and deafness are genetic disorders characterized by diabetes, impaired hearing, and vision." | 5.22 | Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision. ( Gruber, N; Pinhas-Hamiel, O, 2022) |
| "Thiamine-responsive megaloblastic anemia (TRMA), also known as Rogers syndrome, is a rare autosomal recessive disease characterized by three main components: megaloblastic anemia, diabetes mellitus and sensorineural deafness." | 5.01 | [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review]. ( Castioni, J; Lu, H; Tran, C; Vaucher, J; Vollenweider, P, 2019) |
| "Individuals with thiamine-responsive megaloblastic anemia (TRMA) mainly manifest macrocytic anemia, sensorineural deafness, ocular complications, and nonautoimmune diabetes." | 4.31 | An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment. ( Arrigoni, F; Bonfanti, R; Di Candia, F; Di Iorio, V; Fedi, L; Franzese, A; Iafusco, F; Iovino, C; Malesci, R; Mozzillo, E; Rigamonti, A; Rosanio, FM; Simonelli, F; Tinto, N, 2023) |
| " Thiamine supplementation corrected anemia and diabetes mellitus but did not improve the hearing defect." | 4.02 | Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia. ( Li, G; Qiao, Y; Shang, X; Sun, Y; Wang, Z; Zhang, S; Zhuang, J, 2021) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare disease comprising a classic triad of megaloblastic anemia, diabetes mellitus, and early-onset sensorineural deafness." | 3.91 | An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome. ( Kutlucan, A, 2019) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive inherited disease characterized by the clinical triad of megaloblastic anemia, sensorineural deafness, and diabetes mellitus." | 3.91 | TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report. ( Cheng, Q; Ding, Y; Li, Q; Li, X; Wang, J; Wang, X; Yao, R, 2019) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive inherited disorder characterised by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 3.88 | Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child. ( Altaf, C; Fatima, S; Khadim, MT; Khurshid, A; Malik, HS; Sajjad, Z, 2018) |
| " Arrhythmia in thiamine responsive megaloblastic anemia syndrome." | 3.88 | Arrhythmia in thiamine responsive megaloblastic anemia syndrome. ( Akın, L; Argun, M; Baykan, A; Hatipoğlu, N; Kurtoğlu, S; Narin, N; Şahin, Y, 2018) |
| "Thiamine responsive megaloblastic anemia (TRMA) is characterized by a triad of megaloblastic anemia, non-type 1 diabetes mellitus and sensorineural deafness." | 3.80 | Thiamine responsive megaloblastic anemia: the puzzling phenotype. ( Al Zadjali, S; Alrawas, A; Bashir, W; Beshlawi, I; Elshinawy, M; Wali, Y, 2014) |
| "A female child presented with Leber's congenital amaurosis at 10 months of age, later diagnosed with hearing impairment at 1 year, diabetes mellitus and megaloblastic anemia at 3 and a half years of age and hence as a case of thiamine responsive megaloblastic anemia." | 3.80 | Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report. ( Arokiasamy, T; Meenakshi, S; Murali, K; Soumittra, N; Srikrupa, NN, 2014) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is an autosomal recessive syndrome characterized by early-onset anemia, diabetes, and hearing loss caused by mutations in the SLC19A2 gene." | 3.79 | Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia. ( Ellard, S; Haghighi, A; Saleh-Gohari, N; Setoodeh, A, 2013) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a clinical triad characterized by megaloblastic anemia, non-autoimmune diabetes mellitus, and sensory-neural hearing loss." | 3.79 | Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases. ( Abbaszadegan, MR; Baradaran-Heravi, A; Ghaemi, N; Ghahraman, M; Vakili, R, 2013) |
| "The thiamine-responsive megaloblastic anemia syndrome (TRMA) is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anemia and sensorineural hearing loss due to mutations in SLC 19A2 that encodes a thiamine transporter protein." | 3.78 | Thiamine-responsive megaloblastic anemia syndrome: a novel mutation. ( Aycan, Z; Bas, VN; Onder, A; Peltek Kendirci, HN; Yilmaz Agladioglu, S, 2012) |
| "Thiamine-responsive megaloblastic anaemia (TRMA; OMIM 249270) syndrome is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anaemia, and sensorineural deafness." | 3.77 | Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome? ( Akın, L; Akın, MA; Karakükçü, M; Kendirci, M; Kurtoğlu, S, 2011) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome usually associated with diabetes mellitus, anemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein." | 3.76 | Thiamine-responsive megaloblastic anemia syndrome. ( Bay, A; Dai, A; Gumruk, F; Hizli, S; Keskin, M; Uygun, H, 2010) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 3.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "This report describes a female child with thiamine responsive megaloblastic anemia syndrome (Rogers syndrome), presenting with anemia and diabetes mellitus responding to thiamine." | 3.75 | Thiamine responsive megaloblastic anemia. ( Mathews, L; Narayanadas, K; Sunil, G, 2009) |
| "Thiamine-responsive megaloblastic anemia is a rare autosomal recessive disorder whose main symptoms are anemia, diabetes mellitus, and sensorineural deafness." | 3.75 | Thiamine-responsive megaloblastic anemia syndrome: long term follow-up. ( Azzalli, M; Borgna-Pignatti, C; Pedretti, S, 2009) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus and progressive sensorineural deafness." | 3.75 | Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia. ( Ben Mansour, F; Bouyahia, O; Khaldi, F; Matoussi, N; Ouderni, M, 2009) |
| "Thiamine-responsive megaloblastic anaemia (TRMA) is a rare autosomal recessive condition, characterized by megaloblastic anaemia, non-autoimmune diabetes mellitus, and sensorineural hearing loss." | 3.74 | Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood. ( Hahnemann, JM; Olsen, BS; Schwartz, M; Østergaard, E, 2007) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is an autosomal recessive disorder characterized by diabetes mellitus (DM), progressive sensorineural deafness, and thiamine-responsive anemia." | 3.72 | Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome. ( Calikoglu, AS; Lagarde, WH; Moats-Staats, BM; Underwood, LE, 2004) |
| "The triad of thiamine-responsive anaemia, diabetes mellitus and deafness has been reported in 15 patients with macrocytic anaemia, sometimes associated with moderate thrombocytopenia." | 3.70 | Thiamine-responsive myelodysplasia. ( Ayas, M; Bazarbachi, A; Haidar, JH; Muakkit, S; Salem, Z; Solh, H; Taher, A, 1998) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 3.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "Thiamine is a crucial cofactor involved in the maintenance of carbohydrate metabolism and participates in multiple cellular metabolic processes within the cytosol, mitochondria, and peroxisomes." | 2.61 | Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies. ( Baide-Mairena, H; Marcé-Grau, A; Martí-Sánchez, L; Ortigoza-Escobar, JD; Pérez-Dueñas, B, 2019) |
| "Extremely rare cases of Wernicke encephalopathy (WE) can involve sensorineural hearing loss (SNHL)." | 1.91 | A Case of Sensorineural Hearing Loss in Wernicke Encephalopathy. ( Arivoli, K; Benvenuto, A; Stucken, E, 2023) |
| "This case demonstrates Leber congenital amaurosis can present as the first clinical feature before systemic manifestations." | 1.72 | Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome. ( Sui, R; Sun, Z; Wu, S; Yao, F; Yuan, Z, 2022) |
| "Rogers syndrome is an autosomal recessive disorder resulting in megaloblastic anemia, diabetes mellitus, and sensorineural deafness." | 1.32 | Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family. ( Aronheim, A; Assaraf, YG; Baron, D; Drori, S, 2003) |
| "Thiamine (75 mg/day) was commenced at a single oral dose with a rapid increase of Hb level after a few days of therapy." | 1.29 | [Wolfram syndrome. Personal experience]. ( Bizzarri, C; Conti, G; Falsini, B; Marietti, G; Perrone, F; Ricci, B; Zampino, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.02) | 18.7374 |
| 1990's | 5 (8.77) | 18.2507 |
| 2000's | 15 (26.32) | 29.6817 |
| 2010's | 25 (43.86) | 24.3611 |
| 2020's | 8 (14.04) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, S | 1 |
| Yuan, Z | 1 |
| Sun, Z | 1 |
| Yao, F | 1 |
| Sui, R | 1 |
| Gruber, N | 1 |
| Pinhas-Hamiel, O | 1 |
| Arivoli, K | 1 |
| Benvenuto, A | 1 |
| Stucken, E | 1 |
| Khaliq, S | 1 |
| Di Candia, F | 1 |
| Di Iorio, V | 1 |
| Tinto, N | 1 |
| Bonfanti, R | 1 |
| Iovino, C | 1 |
| Rosanio, FM | 1 |
| Fedi, L | 1 |
| Iafusco, F | 1 |
| Arrigoni, F | 1 |
| Malesci, R | 1 |
| Simonelli, F | 1 |
| Rigamonti, A | 1 |
| Franzese, A | 2 |
| Mozzillo, E | 2 |
| Tong, B | 1 |
| Niu, K | 1 |
| Ku, W | 1 |
| Xie, W | 1 |
| Dai, Q | 1 |
| Hellström, S | 1 |
| Duan, M | 1 |
| Nouira, N | 1 |
| Mansouri, R | 1 |
| Tlili, R | 1 |
| Bhouri, I | 1 |
| Sfaxi, S | 1 |
| Chtourou, D | 1 |
| Cheikh, MB | 1 |
| Zhang, S | 1 |
| Qiao, Y | 1 |
| Wang, Z | 1 |
| Zhuang, J | 1 |
| Sun, Y | 1 |
| Shang, X | 1 |
| Li, G | 1 |
| Xian, X | 1 |
| Lin, F | 1 |
| Habeb, AM | 1 |
| Flanagan, SE | 2 |
| Zulali, MA | 1 |
| Abdullah, MA | 1 |
| Pomahačová, R | 1 |
| Boyadzhiev, V | 1 |
| Colindres, LE | 1 |
| Godoy, GV | 1 |
| Vasanthi, T | 2 |
| Al Saif, R | 1 |
| Setoodeh, A | 2 |
| Haghighi, A | 4 |
| Shaalan, Y | 1 |
| Hattersley, AT | 1 |
| Ellard, S | 3 |
| De Franco, E | 1 |
| Lu, H | 2 |
| Vaucher, J | 1 |
| Tran, C | 1 |
| Vollenweider, P | 1 |
| Castioni, J | 1 |
| Khurshid, A | 1 |
| Fatima, S | 1 |
| Altaf, C | 1 |
| Malik, HS | 1 |
| Sajjad, Z | 1 |
| Khadim, MT | 1 |
| Argun, M | 1 |
| Baykan, A | 1 |
| Hatipoğlu, N | 1 |
| Akın, L | 2 |
| Şahin, Y | 1 |
| Narin, N | 1 |
| Kurtoğlu, S | 2 |
| Marcé-Grau, A | 1 |
| Martí-Sánchez, L | 1 |
| Baide-Mairena, H | 1 |
| Ortigoza-Escobar, JD | 1 |
| Pérez-Dueñas, B | 1 |
| Kutlucan, A | 1 |
| Dalwadi, P | 1 |
| Joshi, AS | 1 |
| Thakur, DS | 1 |
| Bhagwat, NM | 1 |
| Li, X | 1 |
| Cheng, Q | 1 |
| Ding, Y | 1 |
| Li, Q | 1 |
| Yao, R | 1 |
| Wang, J | 1 |
| Wang, X | 1 |
| Saleh-Gohari, N | 1 |
| Srikrupa, NN | 1 |
| Meenakshi, S | 1 |
| Arokiasamy, T | 1 |
| Murali, K | 1 |
| Soumittra, N | 1 |
| Ghaemi, N | 1 |
| Ghahraman, M | 1 |
| Abbaszadegan, MR | 1 |
| Baradaran-Heravi, A | 1 |
| Vakili, R | 1 |
| Beshlawi, I | 1 |
| Al Zadjali, S | 1 |
| Bashir, W | 1 |
| Elshinawy, M | 1 |
| Alrawas, A | 1 |
| Wali, Y | 1 |
| Liu, G | 1 |
| Yang, F | 1 |
| Han, B | 1 |
| Liu, J | 1 |
| Nie, G | 1 |
| Wood, MC | 1 |
| Tsiouris, JA | 1 |
| Velinov, M | 1 |
| Mikstiene, V | 1 |
| Songailiene, J | 1 |
| Byckova, J | 1 |
| Rutkauskiene, G | 1 |
| Jasinskiene, E | 1 |
| Verkauskiene, R | 1 |
| Lesinskas, E | 1 |
| Utkus, A | 1 |
| Gul, F | 1 |
| Muderris, T | 1 |
| Yalciner, G | 1 |
| Sevil, E | 1 |
| Bercin, S | 1 |
| Ergin, M | 1 |
| Babademez, MA | 1 |
| Kiris, M | 1 |
| Potter, K | 1 |
| Wu, J | 1 |
| Lauzon, J | 1 |
| Ho, J | 1 |
| Yeşilkaya, E | 1 |
| Bideci, A | 1 |
| Temizkan, M | 1 |
| Kaya, Z | 1 |
| Camurdan, O | 1 |
| Koç, A | 1 |
| Bozkaya, D | 1 |
| Koçak, U | 1 |
| Cinaz, P | 1 |
| Mathews, L | 1 |
| Narayanadas, K | 1 |
| Sunil, G | 1 |
| Ganesh, R | 1 |
| Ezhilarasi, S | 1 |
| Gowrishankar, K | 1 |
| Rajajee, S | 1 |
| Borgna-Pignatti, C | 1 |
| Azzalli, M | 1 |
| Pedretti, S | 1 |
| Bouyahia, O | 1 |
| Ouderni, M | 1 |
| Ben Mansour, F | 1 |
| Matoussi, N | 1 |
| Khaldi, F | 1 |
| Bay, A | 1 |
| Keskin, M | 1 |
| Hizli, S | 1 |
| Uygun, H | 1 |
| Dai, A | 1 |
| Gumruk, F | 1 |
| Kendirci, M | 1 |
| Akın, MA | 1 |
| Karakükçü, M | 1 |
| Kornienko, AM | 1 |
| Kornienko, RA | 1 |
| Antoniv, VF | 1 |
| Efimochkina, KV | 1 |
| Antoniv, TV | 1 |
| Popadiuk, VI | 1 |
| Kakupshev, AU | 1 |
| Yilmaz Agladioglu, S | 1 |
| Aycan, Z | 1 |
| Bas, VN | 1 |
| Peltek Kendirci, HN | 1 |
| Onder, A | 1 |
| Atanesian, AG | 1 |
| Kosiakov, SIa | 1 |
| Melis, D | 1 |
| Falco, M | 1 |
| Fattorusso, V | 1 |
| Taurisano, R | 1 |
| Oishi, K | 1 |
| Hofmann, S | 1 |
| Diaz, GA | 1 |
| Brown, T | 1 |
| Manwani, D | 1 |
| Ng, L | 1 |
| Young, R | 1 |
| Vlassara, H | 1 |
| Ioannou, YA | 1 |
| Forrest, D | 1 |
| Gelb, BD | 1 |
| NAKAHARA, K | 1 |
| KANEKO, Z | 1 |
| OSHITA, F | 1 |
| NIWA, O | 1 |
| YASUDA, Y | 1 |
| NUMAKURA, M | 1 |
| HONMA, T | 1 |
| ONUMA, M | 1 |
| Baron, D | 1 |
| Assaraf, YG | 1 |
| Drori, S | 1 |
| Aronheim, A | 1 |
| Lagarde, WH | 1 |
| Underwood, LE | 1 |
| Moats-Staats, BM | 1 |
| Calikoglu, AS | 1 |
| Manuĭlov, OE | 1 |
| Bezzubenko, LA | 1 |
| Buscaglia, J | 1 |
| Faris, J | 1 |
| Liberman, MC | 1 |
| Tartaglini, E | 1 |
| Fleming, JC | 1 |
| Neufeld, EJ | 2 |
| Alzahrani, AS | 1 |
| Baitei, E | 1 |
| Zou, M | 1 |
| Shi, Y | 1 |
| Olsen, BS | 1 |
| Hahnemann, JM | 1 |
| Schwartz, M | 1 |
| Østergaard, E | 1 |
| Pavlinec, O | 1 |
| Marietti, G | 1 |
| Bizzarri, C | 1 |
| Perrone, F | 1 |
| Zampino, G | 1 |
| Conti, G | 1 |
| Falsini, B | 1 |
| Ricci, B | 1 |
| Akinci, A | 1 |
| Teziç, T | 1 |
| Ertürk, G | 1 |
| Tarim, O | 1 |
| Dalva, K | 1 |
| Mandel, H | 1 |
| Raz, T | 1 |
| Szargel, R | 1 |
| Yandava, CN | 1 |
| Stagg, A | 1 |
| Fauré, S | 1 |
| Barrett, T | 1 |
| Buist, N | 1 |
| Cohen, N | 1 |
| Bazarbachi, A | 1 |
| Muakkit, S | 1 |
| Ayas, M | 1 |
| Taher, A | 1 |
| Salem, Z | 1 |
| Solh, H | 1 |
| Haidar, JH | 1 |
| Villa, V | 1 |
| Rivellese, A | 1 |
| Di Salle, F | 1 |
| Iovine, C | 1 |
| Poggi, V | 1 |
| Capaldo, B | 1 |
| Bappal, B | 1 |
| Nair, R | 1 |
| Shaikh, H | 1 |
| AI Khusaiby, SM | 1 |
| de Silva, V | 1 |
| Wolf, O | 1 |
| Hanson, J | 1 |
5 reviews available for thiamine and Cochlear Hearing Loss
| Article | Year |
|---|---|
Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision.
Topics: Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hearing; Hearing Loss | 2022 |
[Defect of thiamine transport and activation and related disease].
Topics: Anemia, Megaloblastic; Biological Transport; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans; | 2018 |
[Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Diagnosis, Differential; Dietary Supplements; Hearing Loss | 2019 |
Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies.
Topics: Anemia, Megaloblastic; Biological Transport; Biomarkers; Diabetes Mellitus; Hearing Loss, Sensorineu | 2019 |
A comprehensive study of oxidative stress in sudden hearing loss.
Topics: Adult; Biomarkers; Case-Control Studies; Dexamethasone; Disulfides; Female; Free Radical Scavengers; | 2017 |
2 trials available for thiamine and Cochlear Hearing Loss
| Article | Year |
|---|---|
Comparison of Therapeutic Results with/without Additional Hyperbaric Oxygen Therapy in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Prospective Study.
Topics: Adult; Aged; Audiometry, Pure-Tone; Combined Modality Therapy; Drugs, Chinese Herbal; Evoked Potenti | 2021 |
[Milgamma in the treatment of chronic neurosensory hypoacusis].
Topics: Adjuvants, Immunologic; Adult; Aged; Chronic Disease; Hearing Loss, Sensorineural; Humans; Middle Ag | 2004 |
50 other studies available for thiamine and Cochlear Hearing Loss
| Article | Year |
|---|---|
Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
Topics: Adolescent; Anemia, Megaloblastic; Child; China; Diabetes Mellitus; Hearing Loss, Sensorineural; Hum | 2022 |
A Case of Sensorineural Hearing Loss in Wernicke Encephalopathy.
Topics: Female; Hearing Loss, Sensorineural; Humans; Middle Aged; Thiamine; Thiamine Deficiency; Wernicke En | 2023 |
Thiamine responsive megaloblastic anaemia complicated with acute Parvovirus infection: A case report.
Topics: Adolescent; Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans; | 2023 |
An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.
Topics: Adult; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Early Diagnosis; Hearing Loss, Sen | 2023 |
Relapse of rare diseases during COVID-19 pandemic: bicytopenia in an adult patient with thiamine-responsive megaloblastic anaemia.
Topics: Acute Coronary Syndrome; Anemia, Megaloblastic; Betacoronavirus; Chest Pain; Coronavirus Infections; | 2020 |
Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Asia; Diabetes Mellitus; Genetic Association Studies; Hearing Loss, Sensorine | 2021 |
Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
Topics: Alleles; Anemia, Megaloblastic; Child, Preschool; Cohort Studies; Diabetes Mellitus; Female; Genetic | 2018 |
Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
Topics: Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Diabetes Mellitus; Female; Glycated Hemoglob | 2018 |
Arrhythmia in thiamine responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Arrhythmias, Cardiac; Child, Preschool; Diabetes Mellitus; Electrocardiograph | 2018 |
An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome.
Topics: Adult; Anemia, Megaloblastic; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis | 2019 |
Neonatal diabetes mellitus: remission induced by novel therapy.
Topics: Administration, Oral; Anemia, Megaloblastic; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Frame | 2019 |
TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
Topics: Adult; Anemia, Megaloblastic; Arrhythmias, Cardiac; Atrophy; Brain; Cerebral Infarction; Child; Diab | 2019 |
Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Child; Child, Preschool; Codon, Nonsense; Diabetes Mellitus; Female; Genetic | 2013 |
Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Exons; Female; Hearing Loss, Sensorineural; Humans; Infant | 2014 |
Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.
Topics: Anemia, Megaloblastic; Child, Preschool; Consanguinity; Diabetes Mellitus; Female; Hearing Loss, Sen | 2013 |
Thiamine responsive megaloblastic anemia: the puzzling phenotype.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; Humans; Infant; Male; | 2014 |
Identification of four SLC19A2 mutations in four Chinese thiamine responsive megaloblastic anemia patients without diabetes.
Topics: Amino Acid Substitution; Anemia, Megaloblastic; Child; Child, Preschool; Diabetes Mellitus; DNA Muta | 2014 |
Recurrent psychiatric manifestations in thiamine-responsive megaloblastic anemia syndrome due to a novel mutation c.63_71 delACCGCTC in the gene SLC19A2.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans; Ketoglutarate Dehydro | 2014 |
Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
Topics: Anemia, Megaloblastic; Base Sequence; Child, Preschool; Diabetes Mellitus; Hearing Loss, Sensorineur | 2015 |
Beta cell function and clinical course in three siblings with thiamine-responsive megaloblastic anemia (TRMA) treated with thiamine supplementation.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; Humans; Infant; Infan | 2017 |
A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Child, Preschool; Diabetes Mellitus; Diagnosis, Differential; Female; Genotyp | 2009 |
Thiamine responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Child; Comorbidity; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; H | 2009 |
Thiamine responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Diabetes Mellitus, Type 1; Female; Follow-Up | 2009 |
Thiamine-responsive megaloblastic anemia syndrome: long term follow-up.
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Follow-Up Studies; Hearing Loss, Sensorineural; Hu | 2009 |
Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia.
Topics: Anemia, Megaloblastic; Blood Cell Count; Bone Marrow Cells; Diabetes Mellitus; Diabetic Ketoacidosis | 2009 |
Thiamine-responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Blood Component Transfusion; Bone Marrow; Diabetes Mellitus; Hearing Loss, Se | 2010 |
Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome?
Topics: Anemia, Megaloblastic; Diabetes Mellitus; Female; Hearing Loss, Sensorineural; Humans; Infant; Ketog | 2011 |
[Sensorineural hearing loss: New prospects for therapy].
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Audiometry; Disease Progression; Dose-Response R | 2011 |
[The importance of the pharmaceutical form and the routes of administration of B-group vitamins for the efficacious treatment of neurosensorial hearing loss].
Topics: Adult; Biopharmaceutics; Cochlear Nerve; Hearing Loss, Sensorineural; Humans; Male; Nerve Regenerati | 2012 |
Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
Topics: Anemia, Megaloblastic; Child, Preschool; Diabetes Mellitus; Diagnosis, Differential; Female; Follow- | 2012 |
[The role of neurotropic therapy in the treatment of acute sensorineural impairment of hearing following a viral infection].
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Biological Availability; Cochlear Nerve; Drug Monitori | 2012 |
Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
Topics: Adult; Anemia, Megaloblastic; Child; Child, Preschool; Diabetes Mellitus; Female; Hearing Loss, Sens | 2013 |
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice.
Topics: Anemia, Megaloblastic; Animals; Bone Marrow; Brain; Diabetes Mellitus; DNA Primers; Erythrocytes; Ge | 2002 |
[2 CASES OF SLIGHT PERCEPTIVE DEAFNESS CURED BY ASPARA TABLETS].
Topics: Aspartic Acid; Chondroitin; Deafness; Hearing Loss; Hearing Loss, Sensorineural; Humans; Tablets; Th | 1963 |
[The use of sugarcoated alinamin in massive doses in the treatment of inner ear deafness and tinnitus aurium].
Topics: Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Sensorineural; Humans; Thiamine; Tinnitus | 1962 |
[Experience in the use of ATP-2Na (Adephos KOWA) in inner ear deafness and tinnitus].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Senso | 1962 |
Disruption of transport activity in a D93H mutant thiamine transporter 1, from a Rogers Syndrome family.
Topics: Amino Acid Sequence; Anemia, Megaloblastic; Animals; Aspartic Acid; Biological Transport; Cell Line; | 2003 |
Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Black or African American; Diabetes Mellitus; DNA Mutational Analysis; Female | 2004 |
Unsteady, unfocused, and unable to hear.
Topics: Adolescent; Cognition Disorders; Combined Modality Therapy; Female; Fluid Therapy; Gait Disorders, N | 2005 |
Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.
Topics: Animals; Auditory Perception; Hair Cells, Auditory, Inner; Hearing Loss, Sensorineural; Membrane Tra | 2006 |
Thiamine transporter mutation: an example of monogenic diabetes mellitus.
Topics: Adolescent; Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; H | 2006 |
Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
Topics: Anemia, Megaloblastic; Child, Preschool; Consanguinity; Diabetes Complications; Diabetes Mellitus; D | 2007 |
[Can severe hearing damage after epidemic parotitis be prevented?].
Topics: Child; Child, Preschool; Female; Hearing Loss, Sensorineural; Humans; Mumps; Thiamine; Vasodilator A | 1982 |
[Wolfram syndrome. Personal experience].
Topics: Autoantibodies; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Hu | 1995 |
Thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness.
Topics: Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hearing Loss, Sensorine | 1993 |
Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping.
Topics: Alaska; Anemia, Megaloblastic; Arabs; Chromosome Mapping; Chromosomes, Human, Pair 1; Consanguinity; | 1997 |
Thiamine-responsive myelodysplasia.
Topics: Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Humans; Mal | 1998 |
Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome.
Topics: Adult; Anemia, Megaloblastic; Angiography; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorin | 2000 |
Five years followup of diabetes mellitus in two siblings with thiamine responsive megaloblastic anemia.
Topics: Abnormalities, Multiple; Anemia, Megaloblastic; Blood Glucose; Diabetes Mellitus; Female; Follow-Up | 2001 |
[Results of multistep oxygen therapy in the treatment of sudden hearing loss].
Topics: Adult; Combined Modality Therapy; Dipyridamole; Drug Combinations; Drug Therapy, Combination; Female | 1991 |